Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price Target & Predictions
FMS Stock Forecast
Fresenius Medical Care AG & Co. KGaA stock forecast is as follows: an average price target of $17.85 (represents a -10.97% downside from FMS’s last price of $20.05) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.
FMS Price Target
The average price target for Fresenius Medical Care AG & Co. KGaA (FMS) is $17.85 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $24.00 to $11.70. This represents a potential -10.97% downside from FMS's last price of $20.05.
FMS Analyst Ratings
According to 2 Wall Street analysts, Fresenius Medical Care AG & Co. KGaA's rating consensus is 'Hold'. The analyst rating breakdown for FMS stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 2 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Fresenius Medical Care AG & Co. KGaA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 15, 2024 | David MacDonald | Truist Financial | $24.00 | $22.48 | 6.79% | 19.70% |
| Jan 02, 2023 | James Vane-Tempest | Jefferies | $11.70 | $16.34 | -28.40% | -41.65% |
| Jun 22, 2022 | - | Truist Financial | $27.00 | $23.64 | 14.24% | 34.66% |
The latest Fresenius Medical Care AG & Co. KGaA stock forecast, released on May 15, 2024 by David MacDonald from Truist Financial, set a price target of $24.00, which represents a 6.79% increase from the stock price at the time of the forecast ($22.48), and a 19.70% increase from FMS last price ($20.05).
Fresenius Medical Care AG & Co. KGaA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $24.00 |
| Last Closing Price | $20.05 | $20.05 | $20.05 |
| Upside/Downside | -100.00% | -100.00% | 19.70% |
In the current month, the average price target of Fresenius Medical Care AG & Co. KGaA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Fresenius Medical Care AG & Co. KGaA's last price of $20.05. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 23, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jul 31, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| May 13, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jan 02, 2023 | Jefferies | - | Underperform | Downgrade |
Fresenius Medical Care AG & Co. KGaA's last stock rating was published by Citigroup on Oct 23, 2024. The company gave FMS a "Neutral" rating, the same as its previous rate.
Fresenius Medical Care AG & Co. KGaA Financial Forecast
Fresenius Medical Care AG & Co. KGaA Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | $4.70B | $5.00B | $5.10B | $4.76B | $4.55B | $4.65B | $4.44B | $4.32B | $4.21B | $4.40B | $4.41B | $4.56B | $4.49B | $4.58B | $4.42B | $4.35B | $4.13B | $3.98B | $4.55B |
| Avg Forecast | $4.29B | $6.44B | $6.44B | $4.29B | $6.18B | $5.49B | $5.44B | $4.93B | $5.36B | $5.20B | $5.30B | $5.14B | $5.30B | $4.88B | $4.77B | $4.84B | $5.21B | $5.30B | $5.21B | $5.18B | $5.60B | $5.34B | $5.23B | $4.84B | $5.00B | $4.87B | $4.85B | $4.58B | $4.95B | $3.41B |
| High Forecast | $4.29B | $6.44B | $6.44B | $4.29B | $6.18B | $5.54B | $5.63B | $5.11B | $5.53B | $5.20B | $5.30B | $5.14B | $5.30B | $4.88B | $4.77B | $4.84B | $5.21B | $5.30B | $5.21B | $5.18B | $5.60B | $5.34B | $5.23B | $4.84B | $5.00B | $4.87B | $4.85B | $4.58B | $5.94B | $4.09B |
| Low Forecast | $4.29B | $6.44B | $6.44B | $4.29B | $6.18B | $5.46B | $5.24B | $4.74B | $5.12B | $5.20B | $5.30B | $5.14B | $5.30B | $4.88B | $4.77B | $4.84B | $5.21B | $5.30B | $5.21B | $5.18B | $5.60B | $5.34B | $5.23B | $4.84B | $5.00B | $4.87B | $4.85B | $4.58B | $3.96B | $2.73B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 7 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.94% | 1.05% | 1.00% | 0.94% | 0.89% | 0.84% | 0.83% | 0.81% | 0.79% | 0.83% | 0.87% | 0.93% | 0.92% | 0.91% | 0.90% | 0.90% | 0.80% | 1.33% |
Fresenius Medical Care AG & Co. KGaA's average Quarter revenue forecast for Jun 23 based on 1 analysts is $5.30B, with a low forecast of $5.30B, and a high forecast of $5.30B. FMS's average Quarter revenue forecast represents a 12.70% increase compared to the company's last Quarter revenue of $4.70B (Mar 23).
Fresenius Medical Care AG & Co. KGaA EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 7 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | $720.01M | $377.00M | $989.68M | $776.01M | $780.74M | $839.62M | $864.89M | $773.04M | $822.32M | $996.35M | $966.09M | $1.00B | $896.92M | $1.00B | $966.46M | $847.40M | $869.86M | $644.87M | $801.07M |
| Avg Forecast | $539.64M | $809.46M | $809.46M | $539.64M | $777.66M | $691.04M | $683.63M | $644.46M | $674.47M | $654.49M | $666.79M | $585.88M | $434.43M | $613.16M | $599.73M | $532.61M | $654.94M | $666.26M | $848.32M | $651.76M | $703.74M | $671.78M | $658.19M | $1.09B | $628.65M | $612.06M | $609.51M | $797.37M | $803.45M | $600.80M |
| High Forecast | $539.64M | $809.46M | $809.46M | $539.64M | $777.66M | $696.19M | $707.71M | $773.36M | $696.03M | $654.49M | $666.79M | $703.05M | $521.32M | $613.16M | $599.73M | $639.14M | $654.94M | $666.26M | $1.02B | $651.76M | $703.74M | $671.78M | $658.19M | $1.31B | $628.65M | $612.06M | $609.51M | $956.85M | $964.14M | $720.96M |
| Low Forecast | $539.64M | $809.46M | $809.46M | $539.64M | $777.66M | $687.17M | $659.55M | $515.57M | $644.05M | $654.49M | $666.79M | $468.70M | $347.55M | $613.16M | $599.73M | $426.09M | $654.94M | $666.26M | $678.66M | $651.76M | $703.74M | $671.78M | $658.19M | $873.00M | $628.65M | $612.06M | $609.51M | $637.90M | $642.76M | $480.64M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.23% | 0.87% | 1.61% | 1.29% | 1.47% | 1.28% | 1.30% | 0.91% | 1.26% | 1.42% | 1.44% | 1.52% | 0.82% | 1.60% | 1.58% | 1.39% | 1.09% | 0.80% | 1.33% |
1 analysts predict FMS's average Quarter EBITDA for Jun 23 to be $666.79M, with a high of $666.79M and a low of $666.79M. This is -7.39% lower than Fresenius Medical Care AG & Co. KGaA's previous annual EBITDA (Mar 23) of $720.01M.
Fresenius Medical Care AG & Co. KGaA Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 7 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | $133.85M | $194.00M | $230.10M | $206.00M | $211.81M | $303.74M | $273.04M | $218.58M | $248.95M | $177.18M | $353.50M | $350.97M | $282.72M | $342.51M | $332.58M | $253.78M | $270.75M | $278.56M | $308.18M |
| Avg Forecast | $180.24M | $170.58M | $154.49M | $141.62M | $144.49M | $114.65M | $108.80M | $139.63M | $128.27M | $84.38M | $84.65M | $126.94M | $246.86M | $102.44M | $117.93M | $115.40M | $146.65M | $162.06M | $240.01M | $139.30M | $216.13M | $197.76M | $181.85M | $343.97M | $189.77M | $178.44M | $161.35M | $248.19M | $347.05M | $231.13M |
| High Forecast | $180.24M | $170.58M | $154.49M | $141.62M | $144.49M | $114.65M | $112.76M | $167.56M | $135.40M | $84.38M | $84.65M | $152.33M | $296.23M | $102.44M | $117.93M | $138.48M | $146.65M | $162.06M | $288.01M | $139.30M | $216.13M | $197.76M | $181.85M | $412.77M | $189.77M | $178.44M | $161.35M | $297.82M | $416.46M | $277.36M |
| Low Forecast | $180.24M | $170.58M | $154.49M | $141.62M | $144.49M | $114.65M | $104.84M | $111.71M | $121.15M | $84.38M | $84.65M | $101.55M | $197.49M | $102.44M | $117.93M | $92.32M | $146.65M | $162.06M | $192.00M | $139.30M | $216.13M | $197.76M | $181.85M | $275.18M | $189.77M | $178.44M | $161.35M | $198.55M | $277.64M | $184.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 0.79% | 2.25% | 1.75% | 1.84% | 2.07% | 1.68% | 0.91% | 1.79% | 0.82% | 1.79% | 1.93% | 0.82% | 1.80% | 1.86% | 1.57% | 1.09% | 0.80% | 1.33% |
Fresenius Medical Care AG & Co. KGaA's average Quarter net income forecast for Jun 23 is $84.65M, with a range of $84.65M to $84.65M. FMS's average Quarter net income forecast represents a -36.76% decrease compared to the company's last Quarter net income of $133.85M (Mar 23).
Fresenius Medical Care AG & Co. KGaA SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 7 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | $782.15M | $955.00M | $989.61M | $969.49M | $871.24M | $823.21M | $731.23M | $830.18M | $711.51M | $879.37M | $717.75M | $738.08M | $854.46M | $831.40M | $724.43M | $802.53M | $715.16M | $691.88M | $923.13M |
| Avg Forecast | $761.53M | $1.14B | $1.14B | $761.53M | $1.10B | $975.18M | $964.72M | $773.08M | $951.80M | $923.60M | $940.96M | $702.80M | $887.19M | $865.28M | $846.32M | $638.91M | $924.23M | $940.22M | $911.57M | $919.75M | $993.11M | $948.01M | $928.83M | $1.04B | $887.13M | $863.73M | $860.13M | $655.56M | $862.01M | $692.35M |
| High Forecast | $761.53M | $1.14B | $1.14B | $761.53M | $1.10B | $982.46M | $998.70M | $927.70M | $982.22M | $923.60M | $940.96M | $843.36M | $1.06B | $865.28M | $846.32M | $766.69M | $924.23M | $940.22M | $1.09B | $919.75M | $993.11M | $948.01M | $928.83M | $1.25B | $887.13M | $863.73M | $860.13M | $786.67M | $1.03B | $830.82M |
| Low Forecast | $761.53M | $1.14B | $1.14B | $761.53M | $1.10B | $969.72M | $930.74M | $618.46M | $908.87M | $923.60M | $940.96M | $562.24M | $709.76M | $865.28M | $846.32M | $511.13M | $924.23M | $940.22M | $729.25M | $919.75M | $993.11M | $948.01M | $928.83M | $831.68M | $887.13M | $863.73M | $860.13M | $524.45M | $689.61M | $553.88M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.08% | 1.14% | 1.15% | 1.36% | 0.89% | 0.78% | 0.91% | 0.77% | 0.89% | 0.76% | 0.79% | 0.82% | 0.94% | 0.84% | 0.93% | 1.09% | 0.80% | 1.33% |
Fresenius Medical Care AG & Co. KGaA's average Quarter SG&A projection for Jun 23 is $940.96M, based on 1 Wall Street analysts, with a range of $940.96M to $940.96M. The forecast indicates a 20.30% rise compared to FMS last annual SG&A of $782.15M (Mar 23).
Fresenius Medical Care AG & Co. KGaA EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 7 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | $0.23 | $0.33 | $0.39 | $0.35 | $0.36 | $0.52 | $0.47 | $0.38 | $0.42 | $0.30 | $0.60 | $0.60 | $0.47 | $0.57 | $0.55 | $0.42 | $0.44 | $0.46 | $0.51 |
| Avg Forecast | $0.61 | $0.58 | $0.53 | $0.48 | $0.49 | $0.39 | $0.37 | $0.28 | $0.44 | $0.29 | $0.29 | $0.24 | $0.31 | $0.35 | $0.40 | $0.36 | $0.50 | $0.55 | $0.47 | $0.47 | $0.74 | $0.67 | $0.62 | $0.48 | $0.65 | $0.61 | $0.55 | $0.53 | $0.62 | $0.28 |
| High Forecast | $0.61 | $0.58 | $0.53 | $0.48 | $0.49 | $0.39 | $0.38 | $0.29 | $0.46 | $0.29 | $0.29 | $0.24 | $0.31 | $0.35 | $0.40 | $0.36 | $0.50 | $0.55 | $0.47 | $0.47 | $0.74 | $0.67 | $0.62 | $0.48 | $0.65 | $0.61 | $0.55 | $0.53 | $0.74 | $0.34 |
| Low Forecast | $0.61 | $0.58 | $0.53 | $0.48 | $0.49 | $0.39 | $0.36 | $0.27 | $0.41 | $0.29 | $0.29 | $0.24 | $0.31 | $0.35 | $0.40 | $0.36 | $0.50 | $0.55 | $0.47 | $0.47 | $0.74 | $0.67 | $0.62 | $0.48 | $0.65 | $0.61 | $0.55 | $0.53 | $0.49 | $0.22 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 1.08% | 1.12% | 0.87% | 1.01% | 1.04% | 0.84% | 0.79% | 0.90% | 0.41% | 0.90% | 0.97% | 0.98% | 0.88% | 0.90% | 0.76% | 0.83% | 0.74% | 1.80% |
According to 1 Wall Street analysts, Fresenius Medical Care AG & Co. KGaA's projected average Quarter EPS for Jun 23 is $0.29, with a low estimate of $0.29 and a high estimate of $0.29. This represents a 25.43% increase compared to FMS previous annual EPS of $0.23 (Mar 23).
Fresenius Medical Care AG & Co. KGaA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company | $42.33 | $82.33 | 94.50% | Buy |
| SGRY | Surgery Partners | $29.22 | $44.33 | 51.71% | Buy |
| INNV | InnovAge | $5.90 | $6.80 | 15.25% | Hold |
| SEM | Select Medical | $36.51 | $40.00 | 9.56% | Buy |
| PNTG | Pennant Group | $32.38 | $34.67 | 7.07% | Buy |
| ADUS | Addus HomeCare | $128.96 | $129.40 | 0.34% | Buy |
| UHS | Universal Health Services | $208.83 | $208.47 | -0.17% | Hold |
| EHC | Encompass Health | $100.23 | $97.00 | -3.22% | Buy |
| ENSG | Ensign Group | $153.39 | $148.20 | -3.38% | Buy |
| FMS | Fresenius Medical Care AG & Co. KGaA | $20.05 | $17.85 | -10.97% | Hold |
| HCA | HCA Healthcare | $363.16 | $310.75 | -14.43% | Buy |
| THC | Tenet Healthcare | $162.38 | $128.60 | -20.80% | Buy |
FMS Forecast FAQ
Is Fresenius Medical Care AG & Co. KGaA a good buy?
No, according to 2 Wall Street analysts, Fresenius Medical Care AG & Co. KGaA (FMS) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of FMS's total ratings.
What is FMS's price target?
Fresenius Medical Care AG & Co. KGaA (FMS) average price target is $17.85 with a range of $11.7 to $24, implying a -10.97% from its last price of $20.05. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Fresenius Medical Care AG & Co. KGaA stock go up soon?
According to Wall Street analysts' prediction for FMS stock, the company can go down by -10.97% (from the last price of $20.05 to the average price target of $17.85), up by 19.70% based on the highest stock price target, and down by -41.65% based on the lowest stock price target.
Can Fresenius Medical Care AG & Co. KGaA stock reach $30?
FMS's average twelve months analyst stock price target of $17.85 does not support the claim that Fresenius Medical Care AG & Co. KGaA can reach $30 in the near future.
What are Fresenius Medical Care AG & Co. KGaA's analysts' financial forecasts?
Fresenius Medical Care AG & Co. KGaA's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $22.04B (high $22.46B, low $21.63B), average EBITDA is $2.8B (high $2.95B, low $2.64B), average net income is $507.57M (high $539.45M, low $475.68M), average SG&A $3.81B (high $4.01B, low $3.62B), and average EPS is $1.54 (high $1.56, low $1.51). FMS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $21.45B (high $21.45B, low $21.45B), average EBITDA is $2.7B (high $2.7B, low $2.7B), average net income is $646.94M (high $646.94M, low $646.94M), average SG&A $3.81B (high $3.81B, low $3.81B), and average EPS is $2.2 (high $2.2, low $2.2).
Did the FMS's actual financial results beat the analysts' financial forecasts?
Based on Fresenius Medical Care AG & Co. KGaA's last annual report (Dec 2022), the company's revenue was $19.4B, which missed the average analysts forecast of $19.78B by -1.94%. Apple's EBITDA was $1.58B, missing the average prediction of $2.18B by -27.52%. The company's net income was $673M, beating the average estimation of $582.63M by 15.51%. Apple's SG&A was $3.78B, beating the average forecast of $3.24B by 16.87%. Lastly, the company's EPS was $1.15, missing the average prediction of $1.41 by -18.63%. In terms of the last quarterly report (Mar 2023), Fresenius Medical Care AG & Co. KGaA's revenue was $4.7B, missing the average analysts' forecast of $5.14B by -8.42%. The company's EBITDA was $720.01M, beating the average prediction of $585.88M by 22.89%. Fresenius Medical Care AG & Co. KGaA's net income was $133.85M, beating the average estimation of $126.94M by 5.45%. The company's SG&A was $782.15M, beating the average forecast of $702.8M by 11.29%. Lastly, the company's EPS was $0.23, missing the average prediction of $0.242 by -5.14%